Did a quality improvement collaborative make stroke care better? A cluster randomized trial

Table 2 Baseline information for individual data (patient level)

	Intervention		Control		P
Male	2,287	48.2%	2,502	47.3%	0.559
Comorbidities
Atrial fibrillation	714	15.1%	768	14.5%	0.457
Previous stroke or TIA	1,299	27.4%	1,404	26.6%	0.328
Diabetes mellitus	735	15.5%	742	14.0%	0.178
Hyperlipidaemia	647	13.6%	735	13.9%	0.942
Hypertension	2,087	44.0%	2,122	40.1%	0.135
Myocardial infarction or angina	777	16.4%	705	13.3%	0.019
Valvular heart disease	150	3.2%	118	2.2%	0.188
Cardiac failure	113	2.4%	135	2.6%	0.899
Risk factors
Smoker	806	17.0%	765	14.5%	0.064
Ex smoker	733	15.5%	903	17.1%	0.453
Alcohol excess	275	5.8%	304	5.7%	0.692
Patient independent pre stroke	3,285	69.3%	4,031	76.2%	0.384
Readmitted within 28 days	356	7.5%	308	5.8%	0.223
Patient died as inpatient	1,006	21.2%	1,011	19.1%	0.189
Alive at 30 days	3,646	76.9%	3,834	72.5%	0.835
Patient received antibiotics for a newly acquired pneumonia during admission after stroke	298	6.3%	298	5.6%	0.729
Patient had urinary tract infection in first seven days of admission defined by a positive culture or clinically treated	159	3.4%	144	2.7%	0.514
Motor deficits in first 24 hrs of admission	2,534	53.4%	2,795	52.9%	0.727
Dysphasia in first 24 hrs of admission	1,588	33.5%	1,753	33.2%	0.748
Dysarthria in first 24 hrs of admission	1,549	32.7%	1,526	28.9%	0.808
Motor deficits in first 24 hrs of admission	2,534	53.4%	2,795	52.9%	0.879
Patient worst level of consciousness					0.992
Unconscious	527	11.1%	507	9.6%
Confused	264	5.6%	248	4.7%
Drowsy	657	13.9%	884	16.7%
Fully conscious	2,933	61.9%	3,575	67.6%
Not known	360	7.6%	73	1.4%

ISSN: 1748-5908